M-type voltage-gated potassium channel (Kv7)

The M-type voltage-gated potassium channel, primarily composed of heterotetramers of KCNQ2 and KCNQ3 subunits, is a fundamental regulator of neuronal excitability throughout the nervous system. These channels generate the M-current, a slowly activating and non-inactivating potassium current that operates at subthreshold membrane potentials to stabilize the resting potential and prevent repetitive action potential firing. Mutations in the underlying KCNQ genes are well-documented causes of neonatal epilepsy syndromes and severe developmental encephalopathies, highlighting the channel's role in maintaining brain stability. Pharmacological activation of these channels, as seen with the drug retigabine, provides a potent mechanism for suppressing seizures and managing neuropathic pain by dampening neuronal overactivity. Despite their therapeutic promise, clinical application has faced challenges due to off-target effects and specific safety issues like tissue pigmentation and urinary dysfunction.

Other names

KCNQ channelM-channelKv7 channelKCNQ2/3 channelVoltage-gated potassium channel subfamily Q

Drugs targeting these channels primarily act as positive allosteric modulators (openers) that stabilize the open state of the channel, increasing potassium efflux and hyperpolarizing the neuronal membrane to reduce hyperexcitability. Conversely, channel blockers inhibit the M-current to increase neuronal firing, which has been explored for cognitive enhancement.